The North American Fluoroscopy Market size was worth USD 777.67 million in 2022 and is estimated to be growing at a CAGR of 2.80% to reach 892.82 billion by 2027. Fluoroscopy utilizes an X-ray to get constant moving pictures of the inside of the body.
The growing burden of cardiovascular disease in North America is a significant driver of market growth. For instance, according to the Heart Disease and Stroke Statistics 2020 report, it is estimated that by 2020 coronary events are expected to occur in approximately 1,125,624 people, including 832,127 new and 367,821 recurrent coronary events in the United States. According to the Heart and Stroke Foundation's 2020 report, more than 64,520 people suffer from a stroke in Canada each year, and that number is expected to increase. More than 501,125 people in the country are living with the effects of stroke. The number of people who die in the hospital within 90 days is 8.2 times higher for people with valve disease and heart failure than for valve disease alone. Besides, the increase in cardiovascular diseases, such as high blood pressure, arrhythmias, and strokes, increases the demand for fluoroscopic devices and the growing demand for minimally invasive surgeries, and technological advancements are expected to stimulate the market shortly.
However, the radiation risk from exposure to x-ray images is one of the significant factors limiting the global fluoroscopy equipment market's growth. High exposure to ionizing radiation can increase the risk of cancer and radiation-induced burns. Besides, a shortage of medical professionals and a lack of awareness of innovative applications are other factors that are expected to hamper the growth of the global fluoroscopy equipment market during the forecast period.
This research report on the North America Fluoroscopy Market has been segmented and sub-segmented into the following categories:
The global fluoroscopy equipment market had reached $ 190 million, with a CAGR of 3.5% between 2015 and 2020. Subsequently, it will grow to $ 235 million in 2025, with a CAGR of 4.2% between 2020 and 2025. This equipment is steadily used in an extensive range of interventional radiological procedures, mainly in treating conditions such as varicose veins, peripheral arterial disease (PAD), pulmonary embolism, deep vein thrombosis, aneurysms of the abdominal aorta, and other common medical conditions. This continued use is expected to drive the growth potential of the Fluoroscopy Systems market in the future. According to the World Aging 2020 report, it was estimated that in 2020 there were approximately 53.340 million (17.3%) people aged 63 and over in the United States. This number is expected to reach 73.764 million (22.3%) by 2025. As the number of older people is likely to increase shortly, this population is more prone to chronic diseases such as cardiovascular, neurological, and other diseases, which will positively impact the market. Additionally, according to the American Heart Association Research, approximately 2,762 Americans die of cardiovascular disease daily, on average, one death every 40 seconds.
The key players of the North American fluoroscopy market are Philips Healthcare, GE Healthcare, Siemens Medical Solutions, Shimadzu Medical Systems, Shanghai Bojin Medical Instrument Co., Ltd, and Toshiba Medical Systems Corp.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com